Copeptin Serum Level in Liver Transplant Recipients

The study aim is to measure perioperative copeptin concentration in blood of liver transplant recipients and to assess whether there is a correlation between its level and hemodynamic derangement.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liver Cirrhosis Copeptin Diabetes Insipidus Digestive System Diseases Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Fibrosis Kidney Diseases Liver Diseases Liver Transplant Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Pituitary Diseases Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

I Klinika Anestezjologii WUM

Warsaw, Mazovian Voivodeship, 02-005, Poland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient undergoing liver transplantation

Exclusion criteria

Serum creatinine > 1,5 mg/dl
Retransplantation
Patient refusal
CRRT or dialysis preoperatively

Treatment and study plan

Primary outcomes

Serum Copeptin concentration

Time frame: Baseline, intraoperatively, 1,3,7,21 day postoperatively

Sponsors and collaborators

Lead sponsor

Medical University of Warsaw

Other

Registry information

Important dates

Study start: 2018
Primary completion: 2020
Study completion: 2020
First posted: Jul 16, 2018
Registry last updated: Aug 19, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed